Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Shi‐Dong Lu"'
Autor:
Jian-Hong Zhong, Hang Li, Nan Xiao, Xin-Ping Ye, Yang Ke, Yan-Yan Wang, Liang Ma, Jie Chen, Xue-Mei You, Zhi-Yuan Zhang, Shi-Dong Lu, Le-Qun Li
Publikováno v:
PLoS ONE, Vol 9, Iss 9, p e108755 (2014)
Background & aimsOfficial guidelines do not recommend hepatic resection (HR) for patients with hepatocellular carcinoma (HCC) and portal hypertension (PHT). This study aims to investigate the safety and efficacy of HR for patients with HCC and PHT.Me
Externí odkaz:
https://doaj.org/article/5dc2de09d63a4298b451ea5c33ad5325
Autor:
Yu‐Xian Teng, Wan‐Guang Zhang, Anthony Wing‐hung Chan, Charing Ching Ning Chong, Matteo Serenari, Yan‐Yan Wang, Ning Peng, Tao Huang, Shi‐Dong Lu, Zhi‐Yin Liang, Liang Ma, Jian‐Hong Zhong
Publikováno v:
Alimentary Pharmacology & Therapeutics. 57:810-812
Autor:
Philip J. Johnson, B C Xing, T Q Liu, Anthony W.H. Chan, Yan-Yan Wang, Ching-Ning Chong, Z Y Liang, T Huang, Matteo Ravaioli, L-Q Li, R R Huo, Matteo Serenari, Liang Ma, Le-Qun Li, J Neri, Jian-Hong Zhong, Matteo Cescon, B.-D. Xiang, N Peng, Alessandro Cucchetti, Wan-Guang Zhang, Shi-Dong Lu, F X Wu
Publikováno v:
BRITISH JOURNAL OF SURGERY
Background The therapeutic value of repeat hepatic resection (rHR) or radiofrequency ablation (RFA) for recurrent hepatocellular carcinoma (HCC) is unknown. This study aimed to investigate the safety and efficacy of rHR or RFA. Methods This was a ret
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3af86a66f7e99a4270e502f3bcb64342
http://livrepository.liverpool.ac.uk/3148408/1/Manuscript.docx
http://livrepository.liverpool.ac.uk/3148408/1/Manuscript.docx
Autor:
Jian-Hong Zhong, Yan-Yan Wang, Wan-Guang Zhang, Anthony Wing-Hung Chan, Charing C.N. Chong, Matteo Serenari, Ning Peng, Tao Huang, Shi-Dong Lu, Zhi-Yin Liang, Bao-Cai Xing, Matteo Cescon, Tian-Qi Tliu, Lin Li, Le-Qun Li, Matteo Ravaioli, Jacopo Neri, Alessandro Cucchetti, Philip Johnson, Bang-De Xiang
Publikováno v:
Journal of Hepatology. 73:S141-S142
Autor:
Bhavesh K. Ahir, Shi-Dong Lu, Lin Li, Fu-Li Chen, Wan-Guang Zhang, Xin-Min Liang, Wu Chen, Jian-Hong Zhong, Lang-Lin Fan
Publikováno v:
Expert review of gastroenterologyhepatology. 13(11)
Introduction: The 5-year recurrence rate of hepatocellular carcinoma (HCC) after hepatic resection or local ablation is up to 70%. Adjuvant therapies to prevent HCC recurrence have been reported but are not currently recommended by EASL or AASLD guid
Autor:
Shi-Dong Lu, B.-N. Ou, Jian-Hong Zhong, J.-F. Huang, B.-D. Xiang, Liang Ma, Z.-Y. Su, Le-Qun Li, Lu-Nan Qi, Yan-Yan Wang
Publikováno v:
British Journal of Surgery. 103:725-734
Background The Child–Pugh (CP) score is used widely to assess liver function and predict postoperative outcomes in patients with hepatocellular carcinoma (HCC). Recently, the albumin–bilirubin (ALBI) score has been validated as a predictor of ove
Autor:
Jian-Hong Zhong, Zhi-Bo Xie, Xue-Mei You, Le-Qun Li, Ning-Fu Peng, Yu-Chong Peng, Shi-Dong Lu
Publikováno v:
Tumor Biology. 37:10943-10958
This work aims to evaluate the impact of 2-morpholino-8-phenyl-4H-chromen-4-one (LY294002) combined 5-fluorouracil (5-FU) for the activity of CD90+ liver cancer cells derived from the human liver cancer cell line MHCC97H. MHCC97H sphere-forming cells
Autor:
Bang-De Xiang, Hong-Gui Qin, Yan-Yan Wang, Jia-Zhou Ye, Lu-Nan Qi, Jian-Hong Zhong, Liang Ma, Shi-Dong Lu, Le-Qun Li, Xue-Mei You
Publikováno v:
Scientific Reports
To clarify the relationship between aldo-keto reductase family 1 member B10 (AKR1B10) expression and early hepatocellular carcinoma (HCC) recurrence, this study detected AKR1B10 expression in tumor and adjacent non-tumor tissues from 110 patients wit
Autor:
Zhi-Ming Zhang, Xiao-Bo Wang, Shi-Dong Lu, Jian-Hong Zhong, Wen-Feng Gong, Bang-De Xiang, Qiu-Ming Zhang, Le-Qun Li, Liang Ma
Publikováno v:
Oncotarget
// Wen-Feng Gong 1, 2, * , Jian-Hong Zhong 1, 2, * , Shi-Dong Lu 1, 2 , Xiao-Bo Wang 1, 2 , Qiu-Ming Zhang 3 , Liang Ma 1, 2 , Zhi-Ming Zhang 1, 2 , Bang-De Xiang 1, 2 , Le-Qun Li 1, 2 1 Hepatobiliary Surgery Department, Affiliated Tumor Hospital of
Autor:
Yu-Chong Peng, Jian-Hong Zhong, Liang Ma, Le-Qun Li, Xue-Mei You, Bang-De Xiang, Ning-Fu Peng, Hong-Gui Qin, Yan-Yan Wang, Shi-Dong Lu
Publikováno v:
Medicine
This study aims to clarify the prognostic value of the preoperative neutrophil-to-lymphocyte ratio (NLR) for patients with hepatocellular carcinoma (HCC) after potentially curative hepatic resection (HR). The prognostic value of the NLR for HCC patie